The renal patient with coronary artery disease: current concepts and dilemmas

Rajiv Gupta1, Yochai Birnbaum, Barry F Uretsky

  • 1Cardiology Division, University of Texas Medical Branch, Galveston 77555-0553, USA.

Insights

Patients with chronic kidney disease and coronary artery disease (CAD) face unique health challenges. This review explores management strategies and highlights the need for evidence-based treatments through further clinical trials.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) significantly complicates the management of patients with coronary artery disease (CAD).
  • A pro-inflammatory internal environment in CKD patients exacerbates cardiovascular risk.
  • Co-existing CKD and CAD present complex clinical scenarios requiring specialized care.

Purpose of the Study:

  • To review the multifaceted challenges in managing patients with concurrent CKD and CAD.
  • To examine the physiological factors contributing to increased cardiac events in this population.
  • To identify current management issues and unresolved clinical dilemmas.

Main Methods:

  • Literature review focusing on the interplay between CKD and CAD.
  • Analysis of existing data on risk factors and outcomes.
  • Synthesis of current clinical practice guidelines and research gaps.

Main Results:

  • Patients with CKD exhibit a "hostile internal milieu" that promotes atherosclerosis and cardiac events.
  • Standard treatment protocols for CAD may require significant modification in CKD patients.
  • Numerous management dilemmas persist due to limited evidence-based guidelines.

Conclusions:

  • Effective management of CAD in CKD patients requires a comprehensive, multidisciplinary approach.
  • There is a critical need for well-designed randomized controlled trials to establish evidence-based treatment strategies.
  • Addressing the unique pathophysiology of combined CKD and CAD is essential for improving patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...